The Administrative Core will manage the overall progress of the Program Project with the ultimate goal of defining the neurobiological basis of the therapeutic window of opportunity for estrogen and progesterone. The Administrative Core will: 1) hold overall responsibility for the administration of the program project, 2) manage the fiscal aspects of the Program Project, including the set up of project and core accounts, the appointment of new employees and re-appointment of existing personnel to the program accounts, reconciling accounts, reporting budgets to investigators, ordering of reagents and supplies, tracking orders and reporting expenditures to the UNT Health Science Center as well as NIA personnel, 3) manage the interactions between projects and cores, provide statistical support for all projects, and procure and distribute human tissue to the projects, and 4) foster an environment for the intellectual interactions of program investigators and between investigators at the UNT Health Science Center community, and with the research community at large.
The successful interactions among Projects and Cores have, and will continue to be monitored and managed by the Administrative Core through regular meetings/teleconferences. In addition, the Administrative Core will also help shape the long-term goal of identifying improved or novel therapeutic strategies for treating age-associated disorders associated with the menopause and post-menopausal period, including Alzheimer's disease.
|Means, John C; Gerdes, Bryan C; Kaja, Simon et al. (2016) Caspase-3-Dependent Proteolytic Cleavage of Tau Causes Neurofibrillary Tangles and Results in Cognitive Impairment During Normal Aging. Neurochem Res 41:2278-88|
|Bukeirat, Mimi; Sarkar, Saumyendra N; Hu, Heng et al. (2016) MiR-34a regulates blood-brain barrier permeability and mitochondrial function by targeting cytochrome c. J Cereb Blood Flow Metab 36:387-92|
|Engler-Chiurazzi, E B; Singh, M; Simpkins, J W (2016) Reprint of: From the 90×³s to now: A brief historical perspective on more than two decades of estrogen neuroprotection. Brain Res 1645:79-82|
|Sun, Jiahong; Ren, Xuefang; Qi, Wen et al. (2016) Geissoschizine methyl ether protects oxidative stress-mediated cytotoxicity in neurons through the 'Neuronal Warburg Effect'. J Ethnopharmacol 187:249-58|
|Engler-Chiurazzi, E B; Singh, M; Simpkins, J W (2016) From the 90's to now: A brief historical perspective on more than two decades of estrogen neuroprotection. Brain Res 1633:96-100|
|Engler-Chiurazzi, E B; Brown, C M; Povroznik, J M et al. (2016) Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury. Prog Neurobiol :|
|Petrone, Ashley B; O'Connell, Grant C; Regier, Michael D et al. (2016) The Role of Arginase 1 in Post-Stroke Immunosuppression and Ischemic Stroke Severity. Transl Stroke Res 7:103-10|
|Sarkar, S; Jun, S; Rellick, S et al. (2016) Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res 1646:139-51|
|Hu, Heng; Doll, Danielle N; Sun, Jiahong et al. (2016) Mitochondrial Impairment in Cerebrovascular Endothelial Cells is Involved in the Correlation between Body Temperature and Stroke Severity. Aging Dis 7:14-27|
|Strong, Randy; Miller, Richard A; Antebi, Adam et al. (2016) Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an Î±-glucosidase inhibitor or a Nrf2-inducer. Aging Cell 15:872-84|
Showing the most recent 10 out of 111 publications